ResearchDesign and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia.
ResearchOlezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence-TIMI 73b trial.
May 14, 2025Journal ArticleDetection of Hypertrophic Cardiomyopathy on Electrocardiogram Using Artificial Intelligence.Written by 2 Roon authors & 22 others Via The American Heart Association Journals
ResearchA Modified Sampson-NIH Equation with Improved Accuracy for Estimating Low Levels of Low-Density Lipoprotein-Cholesterol.
ResearchA Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk.
ResearchPathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial Participants.
ResearchPolygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic Disease.
ResearchA Tale of Two Scores: Comparing Coronary Artery Calcium and Polygenic Risk Scores for the Prediction of Coronary Heart Disease Events.
ResearchPer-Particle Cardiovascular Risk of Lipoprotein(a) vs Non-Lp(a) Apolipoprotein B-Containing Lipoproteins.
ResearchClonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials.
ResearchRole of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association.
